Logistical challenges of CAR T-cell therapy in non-Hodgkin lymphoma: a survey of healthcare professionals

<b>Aim:</b> Characterize the logistical challenges faced by healthcare professionals (HCPs), patients and caregivers during the chimeric antigen receptor T-cell (CAR T) treatment process for non-Hodgkin lymphoma patients.<b>Materials & methods:</b> HCPs in the US and UK experienced with CAR T administration participated in interviews and completed a web-based survey.<b>Results:</b> A total of 133 (80 US, 53 UK) HCPs participated. Two or more logistical challenges were identified by ≥60% of respondents across all stages of the CAR T process. Commonly reported challenges were lengthy waiting periods, administrative and payer-related barriers, limited healthcare capacity, caregiver support and (particularly in the US) patient out-of-pocket costs.<b>Conclusion:</b> The CAR T treatment process presents numerous challenges, highlighting an unmet need for more convenient therapies.